Consistent bone mineral density gains with intravenous ibandronate injections: Results from the DIVA study.

被引：0
|
作者：
Emkey, R
Halse, J
Kruse, HP
Hughes, C
Ward, P
Masanauskaite, D
Recker, RR
机构：
[1] Radiant Res, Wyomissing, PA USA
[2] Osteoporoseklin, Oslo, Norway
[3] Univ Hamburg, Klinikum Eppendorf, Hamburg, Germany
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Creighton Univ, Omaha, NE 68178 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [11] Intermittent intravenous ibandronate injections are at least as effective as daily oral ibandronate: 1-Year DIVA results
    Lewiecki, M
    Zaidi, M
    Drezner, M
    Recknor, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 802 - 802
  • [12] Consistent efficacy with intermittent intravenous ibandronate injections in postmenopausal osteoporosis: Diva 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S160 - S160
  • [13] Intermittent intravenous ibandronate injections are more effective than daily oral ibandronate for improving bone density at the hip: DIVA 2-year analysis
    Gonzalez Macias, J.
    Prince, R.
    Recker, R. R.
    Mairon, N.
    Masanauskaite, D.
    Hughes, C.
    Reid, D. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 418 - 418
  • [14] Similar safety profile of intravenous ibandronate injection and daily oral ibandronate in postmenopausal osteoporosis: The DIVA study.
    Sambrook, P
    Bianchi, G
    Olszynski, WP
    Leigh, C
    Masanauskaite, D
    Bonvoisin, B
    Emkey, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S296 - S296
  • [15] Two-year safety and tolerability profile of intravenous ibandronate injections: The diva study
    Adami, S.
    Prince, R.
    Halse, J.
    Leigh, C.
    Masanauskaite, D.
    Jonkanski, I.
    Reid, D. M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S69 - S69
  • [16] Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
    Recker, Robert R.
    Ste-Marie, Louis-George
    Langdahl, Bente
    Czerwinski, Edward
    Bonvoisin, Bernard
    Masanauskaite, Daiva
    Rowell, Lucy
    Felsenberg, Dieter
    BONE, 2010, 46 (03) : 660 - 665
  • [17] Association between fracture efficacy and bone mineral density change with ibandronate: Results from the bone study
    Wasnich, R
    Miller, PD
    Huss, H
    Chesnut, CH
    Wilson, K
    Schimmer, RC
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S76 - S76
  • [18] Intermittent intravenous ibandronate injections are an effective treatment option in postmenopausal osteoporosis: 2-year results from diva
    Eisman, J. A.
    Garcia-Hernandez, P. A.
    Ortiz-Luna, G.
    Ste-Marie, L. G.
    Hughes, C.
    Mairon, N.
    Masanauskaite, D.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S212 - S212
  • [19] Renal safety of intravenous ibandronate injections in postmenopausal osteoporosis (PMO): DIVA 1-year results
    Civitelli, R
    Emkey, R
    Bolognese, M
    Recker, R
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 795 - 795
  • [20] Incidence of influenza-like symptoms with intermittent intravenous ibandronate injections:: 1-year results from DIVA
    Reid, DM
    Tankó, LB
    Felsenberg, D
    Adami, S
    Leigh, C
    Ward, P
    Masanauskaite, D
    Delmas, PD
    BONE, 2005, 36 : S425 - S425
12345